Blog - Page 1489 of 5721

ThursdayMar 04, 2021 1:42 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) CEO Talks About Recent Formation of Food Industry Consortium in “Emerging Technology Insider” Video

Pressure BioSciences (OTCQB: PBIO) ("PBI") founder, president and CEO Ric Schumacher was a guest on a recent episode of “Emerging Technology Insider,” which regularly releases video conversations with management of technology companies with business or financial objectives. During the interview, Schumacher focused on the company’s recently announced food industry consortium partnership with The Ohio State University and the impact it may have on the food industry. The agreement between PBI and the College of Food, Agricultural, and Environmental Sciences at Ohio State calls for PBI to install several models of its patented Ultra Shear Technology(TM) ("UST") platform in the state-of-the-art Ohio…

ThursdayMar 04, 2021 1:28 pm

RYAH Group Committed to Advancing Telehealth in HIPAA-Compliant Environment

Telehealth sector going through explosive growth; patients' data protection remains key challenge Although relaxed due to COVID-19 outbreak, HIPAA guidelines protecting patients' data security, privacy likely to tighten as pandemic abates RYAH appears ready to respond to strict data security requirements, uses medical data in a HIPAA-compliant setting Telehealth is becoming increasingly popular with patients and doctors alike, but securing the integrity of patient information remains critical. As a company developing proprietary technology supporting a data-driven healthcare approach, RYAH Group appears ready to respond to the strict data security requirements. With patients needing more access to health care, and providers…

ThursdayMar 04, 2021 1:12 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at Upcoming H.C. Wainwright Global Life Sciences Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the company’s CEO, John Climaco, will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March 9-10, 2021. According to the update, CNSP management will also be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the event. Interested parties should visit https://ibn.fm/XlGLZ for more information and to register for the conference. To view the full press release,…

ThursdayMar 04, 2021 1:08 pm

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Positioned to Benefit as Studies Find CBD Oil Could Help Treat COVID-19 Effects

Medical College of Georgia research shows beneficial effects from use of CBD oil to treat COVID-19 symptoms CBD oil found to increase apelin levels in the human body, a key peptide needed to reduce lung inflammation resulting from COVID-19 PacRoots Cannabis specializes in developing premium quality strains, including plants with high CBD content, rare terpene contents, which could potentially be used for medicinal purposes Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) has developed a strong reputation within the global cannabis sector for producing premium quality strains and products through the employment of a meticulous, genetics-focused approach towards harvesting its crops.…

ThursdayMar 04, 2021 12:44 pm

SRAX Inc.’s (NASDAQ: SRAX) Sequire Investor Analytics Platform Helps Public Companies Monitor Investors Amid Record-Breaking Microcap Trading Activity

Microcap stocks outperforming 2020 record highs, currently trading at 40% above 200-day moving average SRAX’s Sequire SaaS platform provides public companies with tools to monitor trading activity, provides actionable insights for use in marketing campaigns Sequire subscriber base surged to 3 million active traders across 90 public companies since its 2019 inception Investor interest sent microcap stocks sky-high in 2020, a trend that is continuing well into 2021 with returns on some microcap ETFs surging at several times the rate of comparable large-cap ETFs (https://ibn.fm/Bu86D). As the tide of investor interest continues to flow into microcaps, public companies are leveraging…

ThursdayMar 04, 2021 12:34 pm

QualityStocksNewsBreaks – GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) Issues Rio Loa Drilling Update, Prepares for First Phase Drilling at Alicia

GoldHaven Resources (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS), a Canada-based company engaged in the business of acquiring and exploring mineral resource properties, today announced that Phase I drilling continues to advance as planned at Rio Loa. According to the update, the Rio Loa project is located 25 km south of Gold Field's Salares Norte deposit (5.2 million ounces equivalent of gold scheduled to produce 450,000oz of gold per annum*) and 6 km south of Gold Field's Horizonte discovery. The GoldHaven team is actively drilling hole RCRL-003, which is currently in argillic altered limonite-rich volcanic rocks. Silicified volcaniclastic rocks with incipient…

ThursdayMar 04, 2021 12:11 pm

Cybin Inc. (NEO: CYBN) (OTC: CLXPF) Newly Acquired Subsidiary Achieves Earn-Out Milestone —Successful Synthesis of Multiple Tryptamine Derivatives

Adelia Therapeutics has achieved earn-out milestones outlined in contribution agreement with Cybin Adelia ideal acquisition for Cybin, as it leads innovation in researching psychedelic treatment options in the mental health space Acquisition results in Cybin obtaining extensive intellectual property portfolio and product pipeline Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, has announced that its recently acquired subsidiary, Adelia Therapeutics Inc., has achieved the earn-out milestones outlined for the time period in the contribution agreement between the two companies (https://ibn.fm/c6o2E). That milestone includes the successful synthesis of multiple tryptamine derivatives.…

ThursdayMar 04, 2021 11:58 am

QualityStocksNewsBreaks – Asia Broadband Inc. (AABB) Enters LOI to Acquire Mexico-Based Gold Mine and Production Facilities

Asia Broadband (OTC: AABB) today announced its entry into a letter of intent (“LOI”) to acquire a historic production gold mine property and on-site processing facilities in the prolific mining region of Mascota in Jalisco, Mexico. According to the update, the 200-hectare property, located near the community of Navidad, has two mine sites, existing infrastructure and a 50-ton per day processing facility operating on 25 hectares of the property. Asia Broadband has been strategically broadening its initiative to acquire gold production and increase its physical gold holdings. The company will be conducting further due diligence and continuing its negotiations to…

ThursdayMar 04, 2021 11:45 am

Brain Scientific (BRSF) Developing State-of-the-Art AI Diagnostic Analytics

BRSF working to improve diagnostics by leveraging AI and machine learning Cloud-based infrastructure, AI-assisted diagnostic analysis is in development phase Brain Scientific creating long-term monitoring capabilities that leads to collection of essential biomarkers Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, is working on developing state-of-the-art AI diagnostic analytics. The company’s two FDA-cleared products — the NeuroCap(TM) and NeuroEEG(TM) — offer cost-effective disposable alternatives to existing electroencephalogram (“EEG”) solutions. These disposable and simple-to-use devices allow medical professionals to collect necessary diagnostic information quickly. But BRSF isn’t stopping there. The company’s…

ThursdayMar 04, 2021 11:29 am

QualityStocksNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Unveils New Website, Completion of Corporate Rebranding Strategy

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, announced that it has completed its corporate rebranding efforts. Those efforts included the launch of a completely redesigned website. XPhyto chose to rebrand itself as part of its commitment to operational achievement in 2021, which included a number of product-development programs advancing from the laboratory to the clinic. As a bioscience accelerator at the leading-edge of the life science industry, XPhyto is targeting focused investment in impact-driven innovation as well as value creation through commercialization of its development…

Site Search

Company Search